Evidence map›Paper›PMID 33864009›Full record

ArticleNPJ digital medicine2021

Using digital surveillance tools for near real-time mapping of the risk of infectious disease spread.

Sangeeta Bhatia, Britta Lassmann, Emily Cohn, Angel N Desai, Malwina Carrion, Moritz U G Kraemer, Mark Herringer, John Brownstein, Larry Madoff, Anne Cori and 1 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. AI Horizons in Indian Healthcare: A Vision for Transformation and Equity.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sangeeta BhatiaMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Faculty of Medicine, London, UK. s.bhatia@imperial.ac.uk.ORCID http://orcid.org/0000-0001-6525-101X
Britta LassmannProMED, International Society for Infectious Diseases, Brookline, MA, USA.
Emily CohnComputational Epidemiology Group, Division of Emergency Medicine, Boston Children's Hospital, Boston, MA, USA.
Angel N DesaiProMED, International Society for Infectious Diseases, Brookline, MA, USA.
Malwina CarrionProMED, International Society for Infectious Diseases, Brookline, MA, USA.ORCID http://orcid.org/0000-0002-3953-7943
Moritz U G KraemerComputational Epidemiology Group, Division of Emergency Medicine, Boston Children's Hospital, Boston, MA, USA.
Mark Herringerhealthsites.io, London, UK.
John BrownsteinComputational Epidemiology Group, Division of Emergency Medicine, Boston Children's Hospital, Boston, MA, USA.
Larry MadoffProMED, International Society for Infectious Diseases, Brookline, MA, USA.ORCID http://orcid.org/0000-0003-2589-7777
Anne Cori *MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Faculty of Medicine, London, UK.
Pierre Nouvellet *MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Faculty of Medicine, London, UK.

Funding

Medical Research Council MR/R015600/1Wellcome Trust
6 · The paper itself

Abstract

Data from digital disease surveillance tools such as ProMED and HealthMap can complement the field surveillance during ongoing outbreaks. Our aim was to investigate the use of data collected through ProMED and HealthMap in real-time outbreak analysis. We developed a flexible statistical model to quantify spatial heterogeneity in the risk of spread of an outbreak and to forecast short term incidence trends. The model was applied retrospectively to data collected by ProMED and HealthMap during the 2013-2016 West African Ebola epidemic and for comparison, to WHO data. Using ProMED and HealthMap data, the model was able to robustly quantify the risk of disease spread 1-4 weeks in advance and for countries at risk of case importations, quantify where this risk comes from. Our study highlights that ProMED and HealthMap data could be used in real-time to quantify the spatial heterogeneity in risk of spread of an outbreak.

Identifiers

PMID33864009
PMCPMC8052406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.